Vascular endothelial growth factor is constitutively expressed in normal human salivary glands and is secreted in the saliva of healthy individuals

Journal of Pathology

Volumn 186, Issue 2, 1998, Pages 186-191

  Pammer, Johannes ^a   Weninger, Wolfgang ^b   Mildner, Michael ^b   Burian, Martin ^a   Wojta, Johann ^a   Tschachler, Erwin ^b,c  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Universitatsklinik fur Dermatologie   (Austria)

^c Ctr Rech d'Invest Epidermique S   (France)

Author keywords

Fenestration; Saliva; Salivary gland tumours; VEGF; Wound healing

Indexed keywords

VASCULOTROPIN;

ARTICLE; CYTOKINE RELEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; QUANTITATIVE DIAGNOSIS; SALIVA ANALYSIS; WOUND HEALING;

BLOTTING, WESTERN; ENDOTHELIAL GROWTH FACTORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; HUMANS; IMMUNOENZYME TECHNIQUES; IN SITU HYBRIDIZATION; LYMPHOKINES; RNA, MESSENGER; SALIVA; SALIVARY GLAND NEOPLASMS; SALIVARY GLANDS; SIALADENITIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0031667939     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(1998100)186:2<186::AID-PATH148>3.0.CO;2-J     Document Type: Article

References (46)

1. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 1997; 18: 4-25.
2. Ferrara N, Henzel WJ. Pituitary follicular cells secrete a novel heparinbinding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 1989; 161: 851-858.
3. Tischer E, Mitchell R, Hartman T, et al. The human gene for vascular endotheliai growth factor: multiple protein forms are encoded through alternative exon splicing. J Biol Chem 1991; 266: 11947-11954.
4. Houck KA, Ferrara N, Winer J, Cachianes G, Li B, Leung DW. The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol 1991; 6: 1808-1814.
5. de Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 1992; 255: 989-991.
6. Quinn T, Peters KG, De Vries C, Ferrara N, Williams LT. Fetal liver kinase 1 is a receptor for vascular endotheliai growth factor and is selectively expressed in vascular endothelium. Proc Natl Acad Sci USA 1993; 90: 7533-7537.
7. Keck PJ, Hauser SD, Krivi G, et al. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 1989; 146: 1309-1312.
8. Connolly DT, Heuvelman DM, Nelson R, et al. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 1989; 84: 1470-1478.
9. Koch AE, Harlow LA, Haines GK, et al. Vascular endothelial growth factor: a cytokine modulating endothelial function in rheumatoid arthritis. J Immunol 1994; 152: 4149-4156.
10. Senger DR, Galli S, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1983; 219: 983-985.
11. Senger DR, Connolly DT, Van De Water L, Feder J, Dvorak HF. Purification and NH2-terminal amino acid sequence of guinea pig tumor secreted vascular permeability factor. Cancer Res 1990; 50: 1774-1778.
12. Roberts WG, Palade GE. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci 1995; 108: 2369-2379.
13. Li XF, Gregory J, Ahmed A. Immunolocalization of vascular endothelial cell growth in human endometrium. Growth Factors 1994; 11: 277-282.
14. Kamat BR, Brown LF, Manseau EJ, Senger DR, Dvorak HF. Expression of vascular permeability factor/vascular endothelial growth factor by human granulosa and theca lutein cells: role in corpus luteum development. Am J Pathol 1995; 146: 157-165.
15. Breier G, Albrecht U, Sterrer S, Risau W. Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development 1992; 114: 521-532.
16. Brown LF, Yeo KT, Berse B, et al. Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J Exp Med 1992; 176: 1375-1379.
17. Frank S, Hübner G, Breier G, Longaker MT, Greenhalgh DG, Werner S. Regulation of vascular endothelial growth factor expression in cultured keratinocytes. J Biol Chem 1995; 270: 12607-12613.
18. Detmar M, Brown LF, Claffey KP, et al. Overexpression of vascular permeability factor and its receptors in psoriasis. J Exp Med 1994; 180: 1141-1146.
19. Senger DR, Brown LF, Claffey KP, Dvorak HF. Vascular permeability factor, tumor angiogenesis and stroma generation. Invasion Metastasis 1994-95; 14: 385-394.
20. Dvorak HF, Sioussat TM, Brown LF, et al. Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels. J Exp Med 1991; 174: 1275-1278.
21. Dvorak HF, Brown LF, Detmar M, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 1995; 146: 1029-1039.
22. Young JA, Schneyer CA. Composition of saliva in mammalia. Aust J Exp Biol Med Sci 1981; 59: 1-53.
23. Zelles T, Purushotham KR, Macauley SP, Oxford GE, Humphreys-Beher MG. Saliva and growth factors: the fountain of youth resides in us all. J Dent Res 1995; 74: 1826-1831.
24. Hutson JM, Niall M, Evans D, Fowler R. Effects of salivary glands in wound contraction in mice. Nature 1979; 279: 793-795.
25. Bodner L, Knyszynski A, Adler-Kunin S, Danon D. The effect of selective desalivation on wound healing in mice. Exp Geronotol 1991; 26: 357-363.
26. Ino M, Ushiro K, Ino C, Yamashita T, Kumazawa T. Kinetics of epidermal growth factor in saliva. Acta Otolaryngol Suppl Stockholm 1993; 500: 126-130.
27. Humphreys-Beher MG, Macauley SP, Chegini N, et al. Characterization of the synthesis and secretion of transforming growth factor alpha from salivary glands and saliva. Endocrinology 1994; 134: 963-970.
28. van Setten GB. Basic fibroblast growth factor in human saliva: detection and physiological implications. Laryngoscope 1995; 105: 610-612.
29. Ellis GL, Auclair PL. Atlas of Tumor Pathology: Tumors of the Salivary Glands, Washington, DC: Armed Forces Institute of Pathology. 1996.
30. Ballaun C, Weninger W, Uthman A, Weich H, Tschachler E. Human keratinocytes express the three major splice forms of vascular endothelial growth factor. J Invest Dermatol 1995; 104: 7-10.
31. Weninger W, Uthman A, Pammer J, et al. Vascular endothelial growth factor production in normal epidermis and in benign and malignant epithelial skin tumors. Lab Invest 1996; 75: 647-657.
32. Plettenberg A, Ballaun C, Pammer J, et al. Human melanocytes and melanoma cells constitutively express the bcl-2 proto-oncogene in situ and in cell culture. Am J Pathol 1996; 146: 651-659.
33. Conn C, Soderman DD, Schaefer MT, Wile M, Hatcher VB, Thomas KA. Purification of a glycoprotein vascular endothelial cell mitogen from a rat glioma-derived cell line. Proc Natl Acad Sci USA 1990; 87: 1323-1327.
34. Connolly DT, Olander JV, Heuvelman D, et al. Human vascular permeability factor: isolation from U937 cells. J Biol Chem 1989; 264: 20017-20024.
35. Brown LF, Berse B, Tognazzi K, et al. Vascular permeability factor mRNA and protein expression in human kidney. Kidney Int 1992; 42: 1457-1461.
36. Kuroda M, Oka T, Oka Y, et al. Colocalization of vascular endothelial growth factor (vascular permeability factor) and insulin in pancreatic island cells. J Clin Endocrinol Metab 1995; 80: 3196-3200.
37. Watanabe I, Koriyama Y, Yamada E, High-resolution scanning electron microscopic study of the mouse submandibular salivary gland. Acta Anat 1992; 143: 59-66.
38. Cauli A, Yanni G, Pitzalis C, Challacombe S, Panayi GS. Cytoktne and adhesion molecule expression in the minor salivary glands of patients with Sjoegren's syndrome and chronic sialoadenitis. Ann Rheum Dis 1995; 54: 209-215.
39. Bodner L, Dayan D, Rothchild D, Hammel I. Extraction wound healing in desalivated rats. J Oral Pathol Med 1991; 20: 176-178.
40. Bodner L, Dayan D, Oberman M, Hirshberg A, Tal H. Healing of experimental wounds in sialadenectomized rats. J Clin Periodontol 1992; 19: 345-347.
41. Dayan D, Bodner L, Horowitz I. Effect of salivary gland hypofunction on the healing of extraction wounds: a histomorphometric study in rats. J Oral Muxillofac Surg 1992; 50: 354-358.
42. Noguchi S, Ohba Y, Oka T. Effect of salivary epidermal growth factor on wound healing of tongue in mice. Am J Physiol 1991; 260: E620-E625.
43. Goto F, Goto K, Weindel K, Folkman J. Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels. Lab Invest 1993; 69: 508-517.
44. Pepper MS, Ferrara N, Orci L, Montesano R. Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem Biophys Res Commun 1992; 189: 824-831.
45. Niall M, Ryan GB, O'Brien BM. The effect of epidermal growth factor on wound healing in mice. J Surg Res 1982; 33: 164-169.
46. Mawatari M, Kohno K, Mizoguchi H, et al. Effects of tumor necrosis factor and epidermal growth factor on cell morphology, cell surface receptors, and the production of tissue inhibitor of metalloproteinases and IL-6 in human microvascular endothelial cells. J Immunol 1989; 143: 1619-1627.